Wall Street Journal · Brian Gormley ·

Network Bio, which is developing an AI foundation model from datasets of patient tissue and blood samples created by pooling access to biobanks, raised $50M

With $50 million in hand, Network Bio plans to offer virtual access to tissue and blood samples from major academic hospitals

In this story Network Bio

Lead Source

Wall Street Journal — Network Bio, which is developing an AI foundation model from datasets of patient tissue and blood samples created by pooling access to biobanks, raised $50M ↗

How this story grew

Coverage · 0 Discussion · 0

4:02 PM8:32 AM UTC

More

pharmaphorum: pharmaphorum

Network Bio: Network Bio

Discussion

Hani Goodarzi Asad Ali Ahmad, PhD Raphael Potter

Related stories

Unite.AI: Pathway, which is developing AI models based on what it calls its "Post-Transformer" BDH architecture, raised a $30M seed at a $500M valuation

Bloomberg: London-based Callosum, whose software matches AI tasks with different models and chips, raised a $100M seed from Atomico, the UK Sovereign AI Fund, and others

Financial Times: AI video generation startup Higgsfield raised $400M from DST, Goldman Sachs, Liberty Global, Intel, and others at a $5.4B valuation, up from $1.3B in January

SecurityWeek: London- and Boston-based Mindgard, which offers automated AI security and red-teaming tools to help organizations secure AI systems, raised a $30M Series A

Tech Funding News: SF-based Vals, which develops evaluations and benchmarks to test AI models on real-world tasks, raised a $40M Series A led by a16z at a $400M valuation

Discuss with AI

ChatGPT ↗ Claude ↗

← Back to TechSnif